Clinical evaluation of sofosbuvir/ledipasvir in patients with chronic hepatitis C genotype 1 with and without prior daclatasvir/asunaprevir therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical evaluation of sofosbuvir/ledipasvir in patients with chronic hepatitis C genotype 1 with and without prior daclatasvir/asunaprevir therapy

Published:2017-05-06 Issue:12 Volume:47 Page:1308-1316
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatol Res

Author:

Iio Etsuko¹,Shimada Noritomo²,Takaguchi Koichi³,Senoh Tomonori³,Eguchi Yuichiro⁴,Atsukawa Masanori⁵,Tsubota Akihito⁶,Abe Hiroshi⁷,Kato Keizo⁶⁸,Kusakabe Atsunori⁹,Miyaki Tomokatsu¹⁰,Matsuura Kentaro¹,Matsunami Kayoko¹,Shinkai Noboru¹,Fujiwara Kei¹,Nojiri Shunsuke¹,Tanaka Yasuhito¹

Affiliation:

1. Nagoya City University Graduate School of Medical Sciences; Nagoya Japan

2. Otakanomori Hospital; Kashiwa Japan

3. Kagawa Prefectural Central Hospital; Takamatsu Japan

4. Saga University Hospital; Saga Japan

5. Nippon Medical School, Chiba Hokusoh Hospital; Chiba Japan

6. Jikei University School of Medicine; Tokyo Japan

7. Jikei University School of Medicine, Katsushika Medical Center; Tokyo Japan

8. Shinmatsudo Central General Hospital; Matsudo Japan

9. Japanese Red Cross Nagoya Daini Hospital; Nagoya Japan

10. Toyokawa City Hospital; Toyokawa Japan

Funder

the Research Program on Hepatitis from Japan Agency for Medical Research and development, AMED.

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hepr.12898/fullpdf

Reference23 articles.

1. The global burden of hepatitis C;Lavanchy;Liver Int,2009

2. Changing trends in hepatitis C infection over the past 50 years in Japan;Chung;Intervirology,2010

3. Daclatasvir plus asunaprevir for chronic HCV genotype 1b infection;Kumada;Hepatology,2014

4. Efficacy and tolerability of an IFN-free regimen with DCV/ASV for elderly patients infected with HCV genotype 1B;Toyoda;J Hepatol,2017

5. Safety and efficacy of daclatasvir and asunaprevir in hepatitis C virus-infected patients with renal impairment;Suda;Hepatol Res,2016

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ledipasvir/Sofosbuvir is Effective for Relapsed Genotype 1b Hepatitis C Virus Patients after Achieving a Sustained Virological Response at Post-treatment Week 12 with Glecaprevir/Pibrentasvir;Internal Medicine;2023

2. Efficacy and safety of glecaprevir and pibrentasvir in Japanese patients with hepatitis C virus infection aged 75 years or older;BMC Gastroenterology;2022-04-28

3. Mac‐2‐binding protein glycan isomer predicts all malignancies after sustained virological response in chronic hepatitis C;Hepatology Communications;2022-03-28

4. Real‐world safety and effectiveness of ledipasvir/sofosbuvir for the treatment of chronic hepatitis C virus genotype 1 in Japan;Journal of Viral Hepatitis;2020-09-16

5. Twelve weeks of ledipasvir/sofosbuvir all‐oral regimen for patients with chronic hepatitis C genotype 2 infection: Integrated analysis of three clinical trials;Hepatology Research;2020-08-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3